FDA Drug recall D-0325-2020
Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave.,…
- FDA Drug
- Class III
- terminated
- Published 2019-11-20
On 2019-11-20 the FDA classified a Class III recall of Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave.,… by Sato Pharmaceutical, citing subpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0325-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-10-01 |
| Published | 2019-11-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sato Pharmaceutical |
| Distribution | US |
Product
Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946
Reason
Subpotent Drug
Identifiers
| code_info | Lot #: AXTK, AXAK, AXZK, AXNK, AXBK, AXLK, AXPK, AXCK, Exp. Date Nov 2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0325-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.